BioXcel Therapeutics, Inc.
BTAI
DELAYED 1 MONTH

12 insider filings · Latest: May 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 20, 2026May 22 11:02 PMFrank YoccaChief Scientific Officer
Sale
6,845$1.09$7.4K26,175(D)

View →

May 20, 2026May 22 11:02 PMJavier RodriguezChief Legal Officer, Senior Vice President and Corporate Secretary
Sale
6,560$1.08$7.1K26,803(D)

View →

May 20, 2026May 22 11:01 PMRichard I SteinhartChief Financial Officer
Sale
6,845$1.09$7.4K26,300(D)

View →

May 20, 2026May 22 11:00 PMVimal MehtaDirector, CEO and President
Sale
19,419$1.09$21.1K69,598(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 4, 2026May 22 11:02 PMFrank YoccaChief Scientific Officer
Option Exercise
17,500—52,500(D)

View →

May 4, 2026May 22 11:02 PMJavier RodriguezChief Legal Officer, Senior Vice President and Corporate Secretary
Option Exercise
17,500—52,500(D)

View →

May 4, 2026May 22 11:01 PMRichard I SteinhartChief Financial Officer
Option Exercise
17,500—52,500(D)

View →

May 4, 2026May 22 11:00 PMVimal MehtaDirector, CEO and President
Option Exercise
49,758—149,274(D)

View →

May 1, 2026May 7 11:01 PMVimal MehtaDirector, CEO and President
Option Exercise
18,000—0(D)

View →

May 1, 2026May 7 11:01 PMRichard I SteinhartChief Financial Officer
Option Exercise
9,000—0(D)

View →

May 1, 2026May 7 11:00 PMFrank YoccaChief Scientific Officer
Option Exercise
9,000—0(D)

View →

May 1, 2026May 7 11:00 PMJavier RodriguezChief Legal Officer, Senior Vice President and Corporate Secretary
Option Exercise
9,000—0(D)

View →

Mar 15, 2026Mar 17 12:05 AMVimal MehtaDirector, CEO and President
Option Exercise
219—1,532(D)

View →

Mar 14, 2026Mar 17 12:05 AMVimal MehtaDirector, CEO and President
Option Exercise
164—488(D)

View →

Mar 15, 2026Mar 17 12:04 AMRichard I SteinhartChief Financial Officer
Option Exercise
35—247(D)

View →

Mar 14, 2026Mar 17 12:04 AMRichard I SteinhartChief Financial Officer
Option Exercise
33—97(D)

View →

Mar 15, 2026Mar 17 12:03 AMJavier RodriguezChief Legal Officer, Senior Vice President and Corporate Secretary
Option Exercise
35—247(D)

View →

Mar 14, 2026Mar 17 12:03 AMJavier RodriguezChief Legal Officer, Senior Vice President and Corporate Secretary
Option Exercise
33—97(D)

View →

Mar 15, 2026Mar 17 12:01 AMFrank YoccaChief Scientific Officer
Option Exercise
35—247(D)

View →

Mar 14, 2026Mar 17 12:01 AMFrank YoccaChief Scientific Officer
Option Exercise
33—97(D)

View →